KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAProfit After TaxShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

QuidelOrtho (QDEL) Research & Development (2021 - 2024)

QuidelOrtho's Research & Development history spans 3 years, with the latest figure at $118.8 million for Q4 2023.

  • For Q4 2023, Research & Development changed 0.42% year-over-year to $118.8 million; the TTM value through Dec 2023 reached $306.3 million, up 25.28%, while the annual FY2024 figure was $218.7 million, 10.73% down from the prior year.
  • Research & Development for Q4 2023 was $118.8 million at QuidelOrtho, up from $62.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $118.8 million in Q4 2023 and bottomed at $23.7 million in Q4 2021.
  • The 3-year median for Research & Development is $62.4 million (2023), against an average of $63.8 million.
  • The largest annual shift saw Research & Development soared 176.79% in 2022 before it decreased 4.88% in 2023.
  • A 3-year view of Research & Development shows it stood at $23.7 million in 2021, then skyrocketed by 176.79% to $65.6 million in 2022, then surged by 81.1% to $118.8 million in 2023.
  • Per Business Quant, the three most recent readings for QDEL's Research & Development are $118.8 million (Q4 2023), $62.4 million (Q4 2023), and $62.8 million (Q3 2023).